Sign up for our complimentary
weekly e-journal

 
Bookmark and Share | Print | Category | Home Previous | All Articles This Week | Next
This article originally posted 28 January, 2009 and appeared in  Issue 453

First Saliva Test For Type 2 Diabetes

Researchers from India and Oregon have taken a step toward developing the first saliva test to detect and monitor how efficient is the treatment for Type 2 diabetes.
Advertisement
Scientists in Oregon and India are reporting an advance toward developing the first saliva test to diagnose and monitor effectiveness of treatment for Type 2 diabetes. Their report was published in the Jan. 2 issue of ACS' Journal of Proteome Research.

The number of cases of that disease (18 million in the United States alone) has doubled during the last 30 years in parallel with the epidemic of obesity. Researchers say their work represents the first comprehensive description of the proteins in the saliva of patients with Type 2 diabetes, also called non-insulin dependent diabetes.

In the study, Paturi V. Rao and colleagues note that early diagnosis and effective treatment is critical for preventing the disease's complications, including loss of vision, nerve damage, and kidney damage. One important barrier is the need for sometimes-painful needle sticks to draw blood for tests. The discomfort can discourage patients from properly monitoring their blood sugar levels, the scientists say.

The researchers analyzed saliva samples from individuals with and without Type 2 diabetes for protein biomarkers of diabetes. They identified 65 proteins that appeared twice as often in the diabetic samples than the non-diabetic samples. These newly identified proteins could lead to new, noninvasive tests for diabetes screening, detection, and monitoring, the researchers say. MTS

American Chemical Society (ACS), Jan. 2009 ACS' Journal of Proteome Research
 

Bookmark and Share | Print | Category | Home

This article originally posted 28 January, 2009 and appeared in  Issue 453

Past five issues: Issue 537 | Issue 536 | Issue 535 | Issue 534 | Issue 533 |

Diabetes In Control Advertisers
Cast Your Vote
What percent of your Type 2 patients are on oral triple therapy and have an A1c below 6.4%?
Featured Jobs
CME/CE of the Week
Category: Nutrition
CE Credits: .75
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Sponsored Link


Advertisement


Advertisement




Search Articles On Diabetes In Control